AIM clinical leadership team
Our veteran clinical leadership team consists of practicing physicians and experienced executives, including our medical directors. Together, the team ensures that our solutions promote appropriate, safe care and deliver clinical credibility to providers.
Stacey Ban, MD
Stacey Ban, MD, serves as the Vice President and Medical Director for the AIM Medical Oncology Solution. She provides front line clinical expertise including the development of AIM Cancer Treatment Pathways. She played an important role leading the clinical process during the implementation of our solutions for Medical Oncology and Radiation Therapy.
Chris Buckle, MD, MBA, FRCPC
Chris Buckle, MD, serves as the clinical lead for radiology at AIM. In his role, Dr. Buckle is responsible for defining the clinical strategy of our flagship solution.
Varsha Chandramouli, MD
Varsha Chandramouli, MD, is the Vice President, Clinical Operations for AIM. In her role, she is responsible for overseeing the physician and nurse reviewers involved in AIM solutions.
Michael J. Fisch, MD, MPH, FACP, FAAHPM, FASCO
Michael Fisch, MD, serves as National Medical Director of Medical Oncology Programs and Genetics for AIM. In his role, he works closely with the executive leadership team to provide clinical expertise for the expansion of the AIM Medical Oncology Solution and for the AIM Genetic Testing Solution.
Robert Furno, MD, MPH, MBA, FACEP
Dr. Furno is the National Medical Director of Government Programs (Medicare) for AIM. He ensures that all AIM solutions align with government compliance requirements and consistently provide evidence-based, affordable care to health plan beneficiaries.
Rupa I. Nimmagadda, MD, MA
Rupa I. Nimmagadda, MD, MA, serves as Associate Medical Director of Government Programs. Her focus is on providing guidance to ensure that AIM solutions meet government program mandates and requirements for the Medicaid line of business.
Matthew S. Patton, MD
Matthew S. Patton, MD, is Associate Medical Director of the Surgical Procedures Solution at AIM. He provides operational leadership to ensure the solution is both clinically accurate and responsive, based on real-time provider engagement data.
Thomas P. Power, MD, FACC, MRCPI, MBA
Thomas Power, MD, is the National Medical Director of Cardiology, Sleep Medicine, and Surgical Procedures for AIM. Dr. Power is responsible for the clinical components of the Cardiology, Sleep, and Surgical Procedures Solutions.
Kerrie Reed, MD
Kerrie Reed, MD, serves as the clinical lead for the AIM Rehabilitation Solution. In her role, she is responsible for developing the clinical strategy for our Rehabilitation Services Solution as well as supporting provider engagement and growth initiatives.
Richard Valdesuso, MD, MBA, MA
Richard Valdesuso, MD, serves as the National Medical Director of the Musculoskeletal Solution for AIM. In his role, he is responsible for defining the clinical strategy of the solution.
Robert P. Zimmerman, MD
Robert Zimmerman, MD, serves as National Medical Director of Radiation Oncology at AIM. In his role, he provides clinical leadership and guides the development of AIM Guidelines to ensure consistent use of appropriate radiation within our Oncology Solution.